WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

IONS past revenue growth

How has IONS's revenue growth performed historically?
Company
34.1%
Industry
144.63%
Market
17.55%
IONS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
IONS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
IONS's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

IONS earnings and revenue history

Current Revenue
$787.6M
Current Earnings
-$366.3M
Current Profit Margin
-46.5%

IONS Return on Equity

Current Company
-90.6%
Current Industry
-63.5%
Current Market
188%
IONS's Return on Equity (-90.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when IONS announces earnings.

IONS Return on Assets

Current Company
-12.4%
Current Industry
2.9%
IONS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

IONS Return on Capital Employed

Current Company
-9.93%
Current Industry
19.5%
IONS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IONS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
IONS$787.65M-$230.01M-$366.29M+5.60%N/A
APLS$396.59M-$495.21M-$528.63M+83.50%N/A
RVMD$11.58M-$430.28M-$436.37M-10.50%N/A
BPMC$249.38M-$466.45M-$506.98M+41.14%N/A
PCVX$0.00-$392.10M-$402.27MN/AN/A
View Top Biotech Stocks

IONS earnings dates

Next earnings date
Jun 12, 2024

Ionis Pharmaceuticals Earnings & Revenue FAQ

What were IONS's earnings last quarter?

On Invalid Date, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q4 2023 earnings per share (EPS) of -$0.06, up 83.78% year over year. Total Ionis Pharmaceuticals earnings for the quarter were -$9.26 million. In the same quarter last year, Ionis Pharmaceuticals's earnings per share (EPS) was -$0.37.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.

What was IONS's earnings growth in the past year?

As of Q2 2024, Ionis Pharmaceuticals's earnings has grown year over year. Ionis Pharmaceuticals's earnings in the past year totalled -$366.29 million.

What is IONS's earnings date?

Ionis Pharmaceuticals's earnings date is Invalid Date. Add IONS to your watchlist to be reminded of IONS's next earnings announcement.

What was IONS's revenue last quarter?

On Invalid Date, Ionis Pharmaceuticals (NASDAQ: IONS) reported Q4 2023 revenue of $324.51 million up 113.65% year over year. In the same quarter last year, Ionis Pharmaceuticals's revenue was $151.89 million.

What was IONS's revenue growth in the past year?

As of Q2 2024, Ionis Pharmaceuticals's revenue has grown 34.1% year over year. This is 110.53 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Ionis Pharmaceuticals's revenue in the past year totalled $787.65 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.